Intralesional injection of platelet-rich plasma for Peyronie's disease appears to be safe according to early observations from an ongoing clinical trial. Efficacy data remain elusive until completion of the trial.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.euf.2022.08.017 | DOI Listing |
Publication Analysis
Top Keywords
platelet-rich plasma
8
peyronie's disease
8
clinical trial
8
phase randomized
4
randomized placebo-controlled
4
placebo-controlled crossover
4
trial
4
crossover trial
4
trial evaluate
4
evaluate safety
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!